Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:251-255
doi: 10.1161/hs0102.101233
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmalbruch, I. K.
Right arrow Articles by Madsen, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmalbruch, I. K.
Right arrow Articles by Madsen, P. L.
Related Collections
Right arrow Animal models of human disease
Right arrow Energy metabolism
Right arrow Other Research

(Stroke. 2002;33:251.)
© 2002 American Heart Association, Inc.


Original Contributions

Activation-Induced Resetting of Cerebral Metabolism and Flow Is Abolished by ß-Adrenergic Blockade With Propranolol

Ina K. Schmalbruch, MD, PhD; Rasmus Linde, PhD; Olaf B. Paulson, MD, DMSc Peter L. Madsen, MD, DMSc

From the Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Correspondence to O.B. Paulson, Neurobiology Research Unit N9201, Copenhagen University Hospital, Rigshospitalet, 9 Blegdamsvej, DK-2100 Copenhagen Ø, Denmark. E-mail paulson{at}nru.dk

Background and Purpose It has previously been shown that activation will increase cerebral blood flow (CBF) and cerebral glucose uptake (CMRglc) in excess of cerebral oxygen uptake (CMRO2). Our purpose was to investigate the influence of ß-adrenergic blockade with propranolol on the activation-induced uncoupling of cerebral glucose and oxygen metabolism.

Methods Using awake rats, we determined the cerebral arteriovenous differences of oxygen [(a-v)O2], glucose [(a-v)glc], and lactate [(a-v)lac] both under baseline conditions and during activation. The molar ratio between CMRO2 and CMRglc, the oxygen-glucose index (OGI), was calculated.

Results Without ß-adrenergic blockade, activation decreased the (a-v)O2 but not the (a-v)glc, reducing the OGI from 6.1 during baseline conditions to 4.0 under activation (P<0.01). The (a-v)O2 decreased, indicating that the ratio CBF/CMRO2 had increased. Under baseline conditions, a slight flux of lactate from the brain was observed. Activation increased the arterial lactate concentration, and during this condition, the lactate flux from the brain was reversed into a slight lactate uptake. Propranolol administration did not change the behavior of the animals during activation. After administration of propranolol, baseline values were unaffected, but ß-adrenergic blockade totally abolished the activation-induced uncoupling of (a-v)O2 from (a-v)glc, because both remained constant with an unchanged OGI. The unchanged (a-v)O2 indicates that CBF remained unchanged compared with CMRO2.

Conclusions ß-Adrenergic blockade by propranolol abolishes the activation-induced uncoupling of cerebral oxygen to glucose metabolism and the changes in (a-v)O2. This may be of most significance to studies of cerebral activation by the blood oxygen level–dependent fMRI method.


Key Words: cerebral blood flow • cerebral cortex • cerebral metabolism • glucose • lactates • oxygen • propranolol




This article has been cited by other articles:


Home page
J. Physiol.Home page
T. S. Seifert, P. Brassard, T. B. Jorgensen, A. J. Hamada, P. Rasmussen, B. Quistorff, N. H. Secher, and H. B. Nielsen
Cerebral non-oxidative carbohydrate consumption in humans driven by adrenaline
J. Physiol., January 1, 2009; 587(1): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. S. Larsen, P. Rasmussen, M. Overgaard, N. H. Secher, and H. B. Nielsen
Non-selective {beta}-adrenergic blockade prevents reduction of the cerebral metabolic ratio during exhaustive exercise in humans
J. Physiol., June 1, 2008; 586(11): 2807 - 2815.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. H. Secher, T. Seifert, and J. J. Van Lieshout
Cerebral blood flow and metabolism during exercise: implications for fatigue
J Appl Physiol, January 1, 2008; 104(1): 306 - 314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. K. Dalsgaard, S. Ogoh, E. A. Dawson, C. C. Yoshiga, B. Quistorff, and N. H. Secher
Cerebral carbohydrate cost of physical exertion in humans
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R534 - R540.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. K. Dalsgaard, P. Ott, F. Dela, A. Juul, B. K. Pedersen, J. Warberg, J. Fahrenkrug, and N. H. Secher
The CSF and arterial to internal jugular venous hormonal differences during exercise in humans
Exp Physiol, May 1, 2004; 89(3): 271 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. K. Dalsgaard, B. Quistorff, E. R. Danielsen, C. Selmer, T. Vogelsang, and N. H. Secher
A reduced cerebral metabolic ratio in exercise reflects metabolism and not accumulation of lactate within the human brain
J. Physiol., January 15, 2004; 554(2): 571 - 578.
[Abstract] [Full Text] [PDF]